Ex Parte ROBINSON et al - Page 13


                     Appeal No.  2001-2316                                                               Page          13                       
                     Application No.  08/187,879                                                                                                   
                     appellants’ specification provides an enabling description for the full scope of                                              
                     appellants’ claimed invention.  As discussed, supra, the Robinson declaration                                                 
                     fails to demonstrate a complete protective response.  We are also not persuaded                                               
                     by appellants’ rhetorical arguments (Brief, pages 7-8), regarding the virulence                                               
                     and quantity of challenge virus used.  These arguments are not supported by                                                   
                     evidence on this record.  Accordingly, it is our opinion that appellants failed to                                            
                     meet their burden of proof.                                                                                                   
                              On reflection, it is our opinion that the majority of the Wands factors weigh                                        
                     in favor of nonenablement.  Accordingly, we affirm the rejection of claim 44 under                                            
                     35 U.S.C. § 112, first paragraph, as being based on an insufficient disclosure to                                             
                     support or enable the full scope of the claimed invention.  As set forth, supra,                                              
                     claims 45, 46, 50, 51 and 81-89 fall together with claim 44.                                                                  


























Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  Next 

Last modified: November 3, 2007